This has the potential to reduce the $2.6 billion price tag and the 90 percent failure rate for developing new drugs.
In medicine, for example, the ability to analyze large data sets helps drugmakers identify treatments based on the cause of a disease. This has the potential to reduce the $2.6 billion price tag and the 90 percent failure rate for developing new drugs.